top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

19.09 +0.73 (+4.00%)

Streaming Delayed Price Updated: 1:53 PM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday ↗

August 25, 2021

Don't let these companies fly under your radar.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

Via Benzinga

54 Biggest Movers From Yesterday ↗

August 26, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

Via Benzinga

36 Stocks Moving In Wednesday's Mid-Day Session ↗

August 25, 2021

Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. The company's market cap stands at $242.7...

Via Benzinga

BioLife Solutions, inc (BLFS) Q2 2021 Earnings Call Transcript ↗

August 12, 2021

BLFS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: BioLife Solutions Q2 Earnings ↗

August 12, 2021

Shares of BioLife Solutions (NASDAQ:BLFS) moved higher by 4.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00%...

Via Benzinga

Looking Into BioLife Solutions's Return On Capital Employed ↗

May 24, 2021

During Q1, BioLife Solutions (NASDAQ:BLFS) brought in sales totaling $16.85 million. However, earnings decreased 10.24%, resulting in a loss of $1.47 million. BioLife Solutions...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 14, 2021 ↗

May 14, 2021

Upgrades Canaccord Genuity upgraded the previous rating for Mogo Inc (NASDAQ:MOGO) from Hold to Speculative Buy. For the first quarter, Mogo had an EPS of $0.06, compared...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript ↗

May 14, 2021

BLFS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: BioLife Solutions Q1 Earnings ↗

May 13, 2021

Shares of BioLife Solutions (NASDAQ:BLFS) increase in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 83.33% year over...

Via Benzinga

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

Earnings Preview: BioLife Solutions ↗

May 12, 2021

BioLife Solutions (NASDAQ:BLFS) announces its next round of earnings this Thursday, May 13. Here is Benzinga's everything-that-matters guide for this Thursday's Q1 earnings...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page